Ikuo Nomura
Toyoake, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta-analysis.
Journal: Psychiatry and clinical neurosciences
Published: December 22, 2022
Evidence-based insomnia treatment strategy using novel orexin antagonists: A review.
Journal: Neuropsychopharmacology reports
Published: June 30, 2021
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Journal: Molecular psychiatry
Published: April 29, 2021
The Efficacy and Safety of Lacosamide for Bipolar Depression: A 12-Week Open-Label Pilot Trial.
Journal: Journal of clinical psychopharmacology
Published: March 05, 2021
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs.
Journal: Pharmaceutics
Published: February 10, 2021
Lemborexant vs suvorexant for insomnia: A systematic review and network meta-analysis.
Journal: Journal of psychiatric research
Published: April 17, 2020
Suvorexant for insomnia in patients with psychiatric disorder: A 1-week, open-label study.
Journal: Neuropsychopharmacology reports
Published: June 06, 2019
Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis.
Journal: The international journal of neuropsychopharmacology
Published: March 20, 2019
Efficacy and safety of lithium and lamotrigine for the maintenance treatment of clinically stable patients with bipolar disorder: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials with an enrichment design.
Journal: Neuropsychopharmacology reports
Published: January 29, 2019
Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
Journal: Neuropsychiatric disease and treatment
Published: December 19, 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials.
Journal: Neuropsychiatric disease and treatment
Published: October 16, 2018
The efficacy and safety of memantine for the treatment of Alzheimer's disease.
Journal: Expert opinion on drug safety
Published: September 18, 2018
Last Updated: 09/26/2026